Our results showed that NUC1 treatment inhibited the extracellular release of MMPs by blocking TNF-α-induced MMP-1, MMP-3, and MMP-13 expression in chondrosarcoma cells (Fig. 4). This evidence concerns the gene MMP13 and chondrosarcoma.